Observational Study for the Characterisation of Patients Affected by Any Type of Diabetes and Endocrine Disorders
NCT ID: NCT07206875
Last Updated: 2025-10-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
10000 participants
OBSERVATIONAL
2025-11-30
2035-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In case of outpatients, the observation will start at the diagnosis or during the first outpatient visit and will end with the last outpatient visit performed within the total time foreseen for the duration of the study.
The study will start once the regulatory authorizations are completed, and is expected to last at least 10 years with the possibility of extension
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Describing the Clinical-laboratory Aspects of Diabetes Through the Creation of a Registry
NCT06797947
Screening for Undiagnosed Type 2 Diabetes in New Classes of Subjects at High Risk
NCT00520962
AI-Predicted Disease Trajectories in Diabetes: A Retrospective Study
NCT06280729
An International Survey of the Occurrence of Diseases That Affects the Heart and Blood Vessels Among People With Type 2 Diabetes
NCT03786406
Extreme Phenotypes to Identify Susceptibility of Patients Living With Type 2 to Diabetes Related Complications
NCT07250607
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Endocrine-metabolic-disase participants
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Outpatient Diabetes Unit patient
* Ability to give informed consent
Diagnosis of at least one of the following:
* Metabolic disease, defined as BMI ≥25 Kg/m2
* Type 1 or type 2 diabetes mellitus
* Gestational diabetes
* Monogenic diabetes (MODY)
* Other types of diabetes or dysglycemia
* Dyslipidemia
* Arterial hypertension
* Steatosis liver disease (SLD)
Exclusion Criteria
* Deny participation at the study
* Recruitment in an interventional protocol
* Patients with missing significant data
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IRCCS San Raffaele
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
EMANUELA SETOLA
MEDICAL DOCTOR
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Diabetology Department, San Raffaele Scientific Institute
Milan, Italy, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DiabRegistry
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.